Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Dél-Korea
10 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Where
- Daegu, Seoul
- Életkor
- 18 év and over
- People
- 225 worldwide
- Run by
- Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00 - 3. fázisTaking peopleA Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- Where
- Seongnam-si, Seoul
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Takeda
See details and how to joinNCT07422480 · EU 2025-523544-12-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Seoul
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - No phaseNot yet taking people in Dél-KoreaAsia Myelodysplastic Syndrome (MDS) Registry
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07355478 - 1/2. fázisTaking peopleA Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- GangnamGu, SeodaemunGu
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00 - 2. fázisTaking peopleA Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
- Where
- Seongnam-si Gyeonggi-do, Seoul
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06847867 · EU 2024-519928-24-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Hwasun, Seoul
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 1/2. fázisFut, nem toborozClinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Daegu, Pusan, Seongnam, Seoul
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00 - No phaseTaking peopleA Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 104
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06073860